KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank15
3Y CAGR-71.4%
5Y CAGR-48.5%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
-71.4%/yr
vs +18.4%/yr prior
5Y CAGR
-48.5%/yr
Recent deceleration
Acceleration
-89.8pp
Decelerating
Percentile
P15
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $422000.00 | -94.7% |
| 2025 | $7.94M | +48.5% |
| 2024 | $5.35M | -70.2% |
| 2023 | $17.96M | +25.9% |
| 2022 | $14.27M | +22.2% |
| 2021 | $11.68M | +1.2% |
| 2020 | $11.54M | +26.4% |
| 2019 | $9.13M | +214.8% |
| 2018 | $2.90M | -22.4% |
| 2017 | $3.74M | - |